Choose   Change
BGI workshop at ASHG
BGI Advancing Genomics Together
BGI Advancing Research
BGI Advancing Drug Discovery
BGI Advancing Healthcare

BGI and British Columbia Organizations to Collaborate on Precision Medicine

BGI and five British Columbia-based biomedical and healthcare organizations have allied on personalized medicine. The Canadian partners include Providence Health Care, St. Paul's Foundation, the Vancouver Prostate Centre, Genome BC, and Deloitte. Together, the organizations will create "health centers of excellence" in Shenzen, China, where BGI is based, and Vancouver, British Columbia.

Enter Our Competition and Win $5000 of NGS Services!

A unique chance at ASHG to help unlock the potential of your genomics research! Sign up at and get your unique code. Come to our booth #323-325 at the ASHG conference to see if your code unlocks our genomics treasure chest to win $5,000 of FREE NGS services, from one of our ISO, CAP or CLIA certified laboratories around the world.

Discover BGI’s Exome Sequencing Service

– 100 bp and 150bp Paired End sequencing options available
– Guaranteed ≥ 80% of bases with quality score of ≥Q30
– CAP compliant facility in Hong Kong
– US FDA 21 CFR Part 11 compliant processes

ASHG Conference

BGI Will Be Exhibiting At ASHG.

BGI will be exhibiting at the American Society of Human Genetics (ASHG) conference taking place in Vancouver, Canada, 18-22 October. We'll be at booth 323-325. Discover more about our wide range of sequencing services on the industry’s latest NGS platforms or come and speak to one of our knowledgeable staff members about your sequencing project.

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.

About BGI

BGI was founded in 1999 as a nonprofit research organization. Over the years, BGI has grown into a multinational genomics company with significant global operations and a wide variety of next generation sequencing (NGS) services including whole genome sequencingexome sequencing and RNA sequencing. With more than 5,000 employees across the globe and R&D, manufacturing, and commercial operations around the world, BGI is committed to providing genomics solutions to address the research, pharmaceutical, and clinical markets while utilizing the power of NGS technology in order to improve human health and empower large-scale human, plant, and animal genomics research.




On 5


With over 5000


Copyright © BGI 2016